It’s time to consider CAPAs as opportunities rather than just other issues to tackle.
Moving too quickly in the product development process can lead to mistakes.
All industries under the healthcare umbrella should embrace each other’s capabilities because no single category of player can master it and bring to consumers all that we need and demand, says Stephen Bernstein of McDermott Will & Emery.
Companies can improve their chances for a successful transition by leveraging their knowledge of their medical devices and understanding what each device’s categorization under the MDR means to its testing strategy.
Operating with an antiquated QMS raises your risk. Here’s what to consider when modernizing your system.
With the rapid growth of life tech discoveries, there is a need to adapt the patent and regulatory frameworks governing the approval, use, and protection of such discoveries.
This year’s virtual event features experts from medical device companies, hospitals and government organizations.
Don’t miss this opportunity to learn how your company can effectively push its product to the finish line.
Whatever the short- and longer-term fallout of COVID-19, organizations will need to come back fighting—with new tools at their disposal and ready to raise their game.
The outlook for 2020 and beyond is positive, but medical device companies must continue to evolve their technologies and partnerships to keep the attention of investors.